Posted inMedical Technology HeartBeam swells on turning FDA rejection into ECG clearance December 11, 2025 After receiving word late last month that the FDA would not be issuing a 510(k) clearance to its cable-free electrocardiogram,…
Posted inMedical Technology FDA clears Lumosity brain training games as a prescription app for adult ADHD December 11, 2025 Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of…
Posted inMedical Technology FDA approves 1st nondrug, at-home treatment for depression December 10, 2025 The FDA has approved its first at-home, nondrug therapy for depression, a wearable brain stimulation headset developed by Flow Neuroscience. …
Posted inMedical Technology Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer December 10, 2025 Francis Medical is heating up with a 510(k) clearance from the FDA for its water vapor ablation therapy aimed at…
Posted inMedical Technology Teleflex inks $2B in divestment deals for OEM, urology and acute care units December 9, 2025 After announcing plans to split up the company near the top of this year, Teleflex said it has found new…
Posted inMedical Technology Medline sets terms for massive $5.37B Nasdaq IPO December 9, 2025 Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and distribution giant…
Posted inMedical Technology FDA clears Resmed AI for personalizing CPAP settings December 8, 2025 Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep…
Posted inMedical Technology Stryker promotes new president, COO to help lead its M&A strategy December 8, 2025 Stryker, with its eye on tuck-in acquisitions and streamlining its business core, has promoted 27-year veteran Spencer Stiles to president…
Posted inMedical Technology FDA panel votes against J&J’s novel shunt implant for heart failure December 5, 2025 Johnson & Johnson’s billion-dollar bet on a novel implant for heart failure hit a roadblock this week, with an FDA…
Posted inMedical Technology Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M December 5, 2025 Natera is looking to grow its portfolio of tools to detect the recurrence of cancer with a deal to acquire…